Cognition, negative symptoms, and diagnosis: A comparison of schizophrenic, bipolar, and control samples

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 9, Issue 1, 1997, Pages 81-89

  Hawkins, Keith A ^a   Ralph, Psy D ^a   Hoffman, E ^a   Quinlan, Donald M ^a   Rakfeldt, Jaak ^a   Docherty, Nancy M ^a   Sledge, William H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; NEGATIVE SYNDROME; PRIORITY JOURNAL; SCHIZOPHRENIA; TASK PERFORMANCE;

EID: 1842370907     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.9.1.81     Document Type: Article

References (36)

1. Goldberg TE, Gold JM, Braff DL: Neuropsychological functioning and time-linked information processing in schizophrenia, in Review of Psychiatry, vol 10, edited by Tasman A, Goldfinger SM. Washington, DC, American Psychiatric Press, 1991, pp 60-78
2. Crow TJ: Current view of the type II syndrome: significance of age of onset, intellectual impairment and structural changes in the brain, in Negative Schizophrenic Symptoms: Pathophysiology and Clinical Implications, edited by Greden JF, Tandon R. Washington, DC, American Psychiatric Press, 1991, pp 161-171
3. Mukherjee S, Reddy R, Schnur DB: A developmental model of negative syndromes in schizophrenia, in Negative Schizophrenic Symptoms: Pathophysiology and Clinical Implications, edited by Greden JF, Tandon R. Washington, DC, American Psychiatric Press, 1991, pp 173-185
4. Pogue-Geile MF, Harrow M: Negative symptoms in schizophrenia: their longitudinal course and prognostic significance. Schizophr Bull 1985; 11:427-439
5. Hoff AL, Shukla S, Aronson T, et al: Failure to differentiate bipolar disorder from schizophrenia on measures of neuropsychological function. Schizophr Res 1990; 3:253-260
6. Morice R: Cognitive inflexibility and pre-frontal dysfunction in schizophrenia and mania. Br J Psychiatry 1990; 157:50-54
7. Coffman JA, Bornstein RA, Oison SC, et al: Cognitive impairment and cerebral structure by MRI in bipolar disorder. Biol Psychiatry 1990; 27:1188-1196
8. Goldberg TE, Gold JM, Grenberg R, et al: Contrast between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. Am J Psychiatry 1993; 150:1355-1362
9. Andreasen NC, Swayze V, Flaum M, et al: Ventricular abnormalities in affective disorder: clinical and demographic correlates. Am J Psychiatry 1990; 147:893-900
10. Dewan MJ, Haldipur CV, Boucher MF, et al: Bipolar disorder II: EEG, neuropsychological, and clinical correlates of CT abnormality. Acta Psychiatr Scand 1988; 77:677-682
11. Pearlson GD, Garbacz DJ, Breakey WR, et al: Lateral ventricular enlargement associated with persistent unemployment and negative symptoms in both schizophrenia and bipolar disorder. Psychiatry Res 1984; 12:1-9
12. Pearlson GD, Garbacz DJ, Moberg WR, et al: Symptomatic, familial, perinatal, and social correlates of computerized axial tomography (CAT) changes in schizophrenics and bipolars. J Nerv Ment Dis 1985; 173:42-50
13. Spitzer RL, Endicott J: Schedule for Affective Disorders and Schizophrenia-Lifetime Version. New York, New York Psychiatric Institute, 1977
14. Spitzer RL, Endicott J, Robins E: Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatry 1978; 35:773-782
15. Sledge WH, Huffman RE, Hawkins KA, et al: Linguistic deviance in schizophrenia: preliminary report, in Experimental Psychopathology, edited by Spitzer M, Maher B. Cambridge, UK, Cambridge University Press (in press)
16. Hyman SE, Arana GW: Handbook of Psychiatric Drug Therapy. Boston, Little, Brown, 1987
17. Sernyak MJ, Griffin RA, Johnson RM, et al: Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J Psychiatry 1994; 151:133-135
18. Wechsler D: Manual for the Wechsler Adult Intelligence Scale-Revised. New York, The Psychological Corporation, 1981
19. Reitan RM, Davidson LA: Clinical Neuropsychology: Current Status and Applications. New York, Hemisphere, 1974
20. Kaplan E, Goodglass H, Weintraub S: The Boston Naming Test. Philadelphia, Lea and Febiger, 1983
21. Lezak M: Neuropsychological Assessment, 2nd edition. New York, Oxford University Press, 1983
22. MacGinitie WH, MacGinitie RK: Gates-MacGinitie Reading Tests: Manual for Scoring and Interpretation, Levels 7/9 and 10/12, Forms K and L, 3rd edition. Chicago, Riverside, 1989
23. Carpenter WT, Buchanan RW, Kirkpatrick B: The concept of negative symptoms of schizophrenia, in Negative Schizophrenic Symptoms: Pathophysiology and Clinical Implications, edited by Greden JF, Tandon R. Washington, DC, American Psychiatric Press, 1991, pp 3-20
24. Owens DGC, Johnstone EC: The disabilities of chronic schizophrenia. Br J Psychiatry 1980; 136:384-395
25. Guelfi GP, Faustman WO, Csernansky MD: Independence of positive and negative symptoms in a population of schizophrenic patients. J Nerv Ment Dis 1989; 177:285-292
26. Lenzenweger MF, Dworkin RH, Wethington E: Models of positive and negative symptoms in schizophrenia: an empirical evaluation of latent structures. J Abnorm Psychol 1989; 98:62-70
27. Andreasen NC: The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, IA, University of Iowa Press, 1984
28. Andreasen NC: The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, IA, University of Iowa Press, 1984
29. Pernicano KM: Score differences in WAIS-R scatter for schizophrenics, depressives, and personality disorders. Psychol Rep 1986; 59:539-543
30. Derogatis LR: SCL-90-R Administration, Scoring, and Procedures Manual II for the Revised Version. Towson, MD, Clinical Psychometric Research, 1983
31. Chapman LJ, Chapman JP: The measurement of differential deficit. J Psychiatry Res 1978; 14:303-311
32. Chapman LJ, Chapman JP: Strategies for resolving the heterogeneity of schizophrenics and their relatives using cognitive measures. J Abnorm Psychol 1989; 98:357-366
33. Spohn HE, Strauss ME: Relation of neuroleptic and anticholinergic medication to cognitive function in schizophrenia. J Abnorm Psychol 1989; 98:367-380
34. Heaton RK, Drexler M: Clinical neuropsychological findings in schizophrenia and aging, in Schizophrenia and Aging: Schizophrenia, Paranoia, and Schizophreniform Disorders in Later Life, edited by Miller NE, Cohen GD. New York, Guilford, 1987, pp 145-161
35. Hyde TM, Nawroz S, Goldberg TE, et al: Is there cognitive decline in schizophrenia? A cross sectional study. Br J Psychiatry 1994; 164: 494-500
36. Greden JF, Tandon R (eds): Negative Schizophrenic Symptoms: Pathophysiology and Clinical Implications. Washington, DC, American Psychiatric Press, 1991